199 related articles for article (PubMed ID: 34589289)
1. CRISPR-Cas9 correction of
Sladen PE; Perdigão PRL; Salsbury G; Novoselova T; van der Spuy J; Chapple JP; Yu-Wai-Man P; Cheetham ME
Mol Ther Nucleic Acids; 2021 Dec; 26():432-443. PubMed ID: 34589289
[TBL] [Abstract][Full Text] [Related]
2. Modelling autosomal dominant optic atrophy associated with OPA1 variants in iPSC-derived retinal ganglion cells.
Sladen PE; Jovanovic K; Guarascio R; Ottaviani D; Salsbury G; Novoselova T; Chapple JP; Yu-Wai-Man P; Cheetham ME
Hum Mol Genet; 2022 Oct; 31(20):3478-3493. PubMed ID: 35652445
[TBL] [Abstract][Full Text] [Related]
3. Dominant optic atrophy: Culprit mitochondria in the optic nerve.
Lenaers G; Neutzner A; Le Dantec Y; Jüschke C; Xiao T; Decembrini S; Swirski S; Kieninger S; Agca C; Kim US; Reynier P; Yu-Wai-Man P; Neidhardt J; Wissinger B
Prog Retin Eye Res; 2021 Jul; 83():100935. PubMed ID: 33340656
[TBL] [Abstract][Full Text] [Related]
4. Establishing induced pluripotent stem cell lines from two dominant optic atrophy patients with distinct
Pohl KA; Zhang X; Pham AH; Chan JW; Sadun AA; Yang XJ
Front Genet; 2023; 14():1251216. PubMed ID: 37745862
[TBL] [Abstract][Full Text] [Related]
5. Dominant optic atrophy.
Lenaers G; Hamel C; Delettre C; Amati-Bonneau P; Procaccio V; Bonneau D; Reynier P; Milea D
Orphanet J Rare Dis; 2012 Jul; 7():46. PubMed ID: 22776096
[TBL] [Abstract][Full Text] [Related]
6. OPA1 gene therapy prevents retinal ganglion cell loss in a Dominant Optic Atrophy mouse model.
Sarzi E; Seveno M; Piro-Mégy C; Elzière L; Quilès M; Péquignot M; Müller A; Hamel CP; Lenaers G; Delettre C
Sci Rep; 2018 Feb; 8(1):2468. PubMed ID: 29410463
[TBL] [Abstract][Full Text] [Related]
7. Autosomal dominant optic atrophy with
Maeda-Katahira A; Nakamura N; Hayashi T; Katagiri S; Shimizu S; Ohde H; Matsunaga T; Kaga K; Nakano T; Kameya S; Matsuura T; Fujinami K; Iwata T; Tsunoda K
Mol Vis; 2019; 25():559-573. PubMed ID: 31673222
[TBL] [Abstract][Full Text] [Related]
8. Optimized OPA1 Isoforms 1 and 7 Provide Therapeutic Benefit in Models of Mitochondrial Dysfunction.
Maloney DM; Chadderton N; Millington-Ward S; Palfi A; Shortall C; O'Byrne JJ; Cassidy L; Keegan D; Humphries P; Kenna P; Farrar GJ
Front Neurosci; 2020; 14():571479. PubMed ID: 33324145
[TBL] [Abstract][Full Text] [Related]
9. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion.
Zanna C; Ghelli A; Porcelli AM; Karbowski M; Youle RJ; Schimpf S; Wissinger B; Pinti M; Cossarizza A; Vidoni S; Valentino ML; Rugolo M; Carelli V
Brain; 2008 Feb; 131(Pt 2):352-67. PubMed ID: 18222991
[TBL] [Abstract][Full Text] [Related]
10. OPA1 expression in the normal rat retina and optic nerve.
Ju WK; Misaka T; Kushnareva Y; Nakagomi S; Agarwal N; Kubo Y; Lipton SA; Bossy-Wetzel E
J Comp Neurol; 2005 Jul; 488(1):1-10. PubMed ID: 15912498
[TBL] [Abstract][Full Text] [Related]
11. Loss of OPA1 disturbs cellular calcium homeostasis and sensitizes for excitotoxicity.
Kushnareva YE; Gerencser AA; Bossy B; Ju WK; White AD; Waggoner J; Ellisman MH; Perkins G; Bossy-Wetzel E
Cell Death Differ; 2013 Feb; 20(2):353-65. PubMed ID: 23138851
[TBL] [Abstract][Full Text] [Related]
12. Dominant Optic Atrophy (DOA): Modeling the Kaleidoscopic Roles of OPA1 in Mitochondrial Homeostasis.
Del Dotto V; Carelli V
Front Neurol; 2021; 12():681326. PubMed ID: 34177786
[TBL] [Abstract][Full Text] [Related]
13. Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene.
Formichi P; Radi E; Giorgi E; Gallus GN; Brunetti J; Battisti C; Rufa A; Dotti MT; Franceschini R; Bracci L; Federico A
J Neurol Sci; 2015 Apr; 351(1-2):99-108. PubMed ID: 25796301
[TBL] [Abstract][Full Text] [Related]
14. Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function.
Davies VJ; Hollins AJ; Piechota MJ; Yip W; Davies JR; White KE; Nicols PP; Boulton ME; Votruba M
Hum Mol Genet; 2007 Jun; 16(11):1307-18. PubMed ID: 17428816
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated mitophagy and mitochondrial organization in optic atrophy due to OPA1 mutations.
Liao C; Ashley N; Diot A; Morten K; Phadwal K; Williams A; Fearnley I; Rosser L; Lowndes J; Fratter C; Ferguson DJ; Vay L; Quaghebeur G; Moroni I; Bianchi S; Lamperti C; Downes SM; Sitarz KS; Flannery PJ; Carver J; Dombi E; East D; Laura M; Reilly MM; Mortiboys H; Prevo R; Campanella M; Daniels MJ; Zeviani M; Yu-Wai-Man P; Simon AK; Votruba M; Poulton J
Neurology; 2017 Jan; 88(2):131-142. PubMed ID: 27974645
[TBL] [Abstract][Full Text] [Related]
16. OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease.
Delettre C; Lenaers G; Pelloquin L; Belenguer P; Hamel CP
Mol Genet Metab; 2002 Feb; 75(2):97-107. PubMed ID: 11855928
[TBL] [Abstract][Full Text] [Related]
17. Genetic screening for OPA1 and OPA3 mutations in patients with suspected inherited optic neuropathies.
Yu-Wai-Man P; Shankar SP; Biousse V; Miller NR; Bean LJ; Coffee B; Hegde M; Newman NJ
Ophthalmology; 2011 Mar; 118(3):558-63. PubMed ID: 21036400
[TBL] [Abstract][Full Text] [Related]
18. Dominant optic atrophy: updates on the pathophysiology and clinical manifestations of the optic atrophy 1 mutation.
Chun BY; Rizzo JF
Curr Opin Ophthalmol; 2016 Nov; 27(6):475-480. PubMed ID: 27585216
[TBL] [Abstract][Full Text] [Related]
19. OPA1 mutations cause cytochrome c oxidase deficiency due to loss of wild-type mtDNA molecules.
Yu-Wai-Man P; Sitarz KS; Samuels DC; Griffiths PG; Reeve AK; Bindoff LA; Horvath R; Chinnery PF
Hum Mol Genet; 2010 Aug; 19(15):3043-52. PubMed ID: 20484224
[TBL] [Abstract][Full Text] [Related]
20. Genomics combined with a protein informatics platform to assess a novel pathogenic variant c.1024 A>G (p.K342E) in OPA1 in a patient with autosomal dominant optic atrophy.
Ahuja AS; Selvam P; Vadlamudi C; Chopra H; Richter JE; Macklin SK; Samreen A; Helmi H; Mohammaad AN; Hines S; Davila MC; Atwal PS; Caulfield TR
Ophthalmic Genet; 2020 Dec; 41(6):563-569. PubMed ID: 32940104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
